We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+29.7%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.09B
AUM Growth
+$568M
(+109%)
Cap. Flow
+$422M
Cap. Flow
% of AUM
38.69%
Top 10 Holdings %
Top 10 Hldgs %
23.6%
Holding
197
New
132
Increased
39
Reduced
16
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$26.1M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$20M |
| 3 |
Arvinas
ARVN
|
+$19.8M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$19.7M |
| 5 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aprea Therapeutics
APRE
|
+$18.2M |
| 2 |
KYNB
Kyntra Bio
KYNB
|
+$12M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$10.7M |
| 4 |
Teladoc Health
TDOC
|
+$10.1M |
| 5 |
Biogen
BIIB
|
+$8.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 86.26% |
| 2 | Industrials | 4.93% |
| 3 | Technology | 1.47% |
| 4 | Energy | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioMarin Pharmaceuticals
BMRN
$11.9B
| $16.2M | 1.49% |
131,623
-52,388
| -28% | -$5.21M |
|
|
CHNG
27
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $16M | 1.47% |
1,426,832
+779,937
| +121% | +$8.76M |
|
|
28
Arvinas
ARVN
$530M
| $15.7M | 1.44% |
+467,000
| New | +$19.8M |
|
29
Assembly Biosciences
ASMB
$498M
| $15.3M | 1.41% |
54,760
+3,969
| +8% | +$926K |
|
30
Molina Healthcare
MOH
$10.4B
| $14.9M | 1.36% |
+83,453
| New | +$14.2M |
|
31
Incyte
INCY
$25.8B
| $14.6M | 1.34% |
140,424
+123,424
| +726% | +$11.9M |
|
|
GBT
32
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $14.5M | 1.33% |
229,271
+51,977
| +29% | +$3.57M |
|
|
MRTX
33
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $14.3M | 1.31% |
125,336
+51,236
| +69% | +$4.97M |
|
|
ALXN
34
DELISTED
Alexion Pharmaceuticals
ALXN
| $14.1M | 1.3% |
+125,776
| New | +$13.4M |
|
35
Sarepta Therapeutics
SRPT
$1.64B
| $14.1M | 1.29% |
87,774
-38,985
| -31% | -$5.31M |
|
36
ResMed
RMD
$31.1B
| $13.9M | 1.27% |
+72,305
| New | +$11.8M |
|
|
SGEN
37
DELISTED
Seagen Inc. Common Stock
SGEN
| $13.9M | 1.27% |
81,576
-25,424
| -24% | -$3.79M |
|
38
iRhythm Holdings
IRTC
$4.02B
| $13.4M | 1.23% |
115,895
+25,670
| +28% | +$2.83M |
|
|
DCPH
39
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $13.4M | 1.23% |
224,359
+20,300
| +10% | +$1.09M |
|
40
Bristol-Myers Squibb
BMY
$129B
| $13.2M | 1.21% |
224,974
+33,000
| +17% | +$1.97M |
|
41
Evolent Health
EVH
$371M
| $13M | 1.19% |
1,822,297
+476,625
| +35% | +$3.19M |
|
42
Collegium Pharmaceutical
COLL
$1.18B
| $11.5M | 1.05% |
654,521
+210,000
| +47% | +$4.11M |
|
43
uniQure
QURE
$2.78B
| $11.3M | 1.04% |
251,158
+87,758
| +54% | +$5.18M |
|
44
Regeneron Pharmaceuticals
REGN
$72.9B
| $11.2M | 1.03% |
18,038
+10,268
| +132% | +$5.83M |
|
|
FMTX
45
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $11M | 1.01% |
+237,174
| New | +$10.3M |
|
46
UnitedHealth
UNH
$382B
| $10.8M | 0.99% |
36,514
+17,050
| +88% | +$4.89M |
|
|
GBIO
47
DELISTED
Generation Bio
GBIO
| $10.7M | 0.99% |
+51,130
| New | +$11.4M |
|
48
AbbVie
ABBV
$465B
| $10.3M | 0.94% |
104,750
+21,000
| +25% | +$1.85M |
|
49
Repligen
RGEN
$6.91B
| $10.2M | 0.93% |
+82,383
| New | +$9.69M |
|
|
PRAH
50
DELISTED
PRA Health Sciences, Inc.
PRAH
| $9.7M | 0.89% |
99,700
+29,785
| +43% | +$2.77M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Sectoral Asset Management held 197 positions worth $1.09B, up 109% from $521M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Sectoral Asset Management deployed $422M of net new capital in Q2 2020, opening 132 new positions and adding to 39 existing holdings. Its largest new stake was Centene: 401,158 shares worth $25.5M.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 86% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Aprea Therapeutics, an estimated $18.2M trimmed.
- Sectoral Asset Management's largest Q2 2020 buy was Centene: 401,158 shares worth $25.5M.
- Sectoral Asset Management added most to Cardiovascular Systems, Inc. in Q2 2020, an estimated $18.2M increase.
- Sectoral Asset Management's biggest Q2 2020 reduction was Aprea Therapeutics, cutting an estimated $18.2M.
- Sectoral Asset Management fully exited Inspire Medical Systems in Q2 2020, selling an estimated $6.81M.
- Sectoral Asset Management's ten largest holdings make up 24% of its $1.09B portfolio in Q2 2020.
- Sectoral Asset Management opened 132 new positions and closed 6 in Q2 2020.
- Sectoral Asset Management's portfolio value rose 109% quarter-over-quarter to $1.09B.
Based on Sectoral Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.